These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6367794

  • 1. "24-hour blood pressure control" with sustained release oxprenolol 160mg plus cyclopenthiazide 0.25mg (Trasidrex) in general practice.
    Forrest WA, Bridgman KM, Ebbutt AF.
    Br J Clin Pract; 1983; 37(11-12):385-8. PubMed ID: 6367794
    [No Abstract] [Full Text] [Related]

  • 2. Experience with Trasidrex in the management of inadequately controlled hypertension in general practice.
    Forrest WA.
    Br J Clin Pract; 1980 May; 34(5):140-3. PubMed ID: 6893270
    [No Abstract] [Full Text] [Related]

  • 3. [Evaluation of the hypotensive effect of slow-release Trasicor].
    Cybulska I, Brym E.
    Kardiol Pol; 1982 May; 25(4):329-35. PubMed ID: 6755030
    [No Abstract] [Full Text] [Related]

  • 4. The treatment of hypertension in older patients: a comparative study between a diuretic, a beta-receptor antagonist and their fixed combination.
    Forrest WA.
    Practitioner; 1982 Apr; 226(1366):777-8. PubMed ID: 7045851
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of a combination of diuretic, beta-blocker and vasodilator in the treatment of hypertension in general practice.
    Forrest WA.
    Br J Clin Pract; 1978 Nov; 32(11):326-32. PubMed ID: 737111
    [No Abstract] [Full Text] [Related]

  • 6. Use of a sustained-release formulation of oxprenolol and cyclopenthiazide ('Trasidrex') in the management of hypertension: a general practice study.
    Forrest WA.
    Curr Med Res Opin; 1980 Nov; 6(8):559-63. PubMed ID: 7389387
    [Abstract] [Full Text] [Related]

  • 7. [2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
    Gyntelberg F, Jacobsen K, Martlev A, Backer P.
    Ugeskr Laeger; 1977 Mar; 139(11):641-6. PubMed ID: 320734
    [No Abstract] [Full Text] [Related]

  • 8. A comparison of slow Trasicor (oxprenolol 160 mg) and Trasidrex (oxprenolol 160 mg and cyclopenthiazide 0.25 mg) in the treatment of hypertension in general practice.
    Elsdon-Dew RW, Holden E.
    J Int Med Res; 1981 Mar; 9(5):315-8. PubMed ID: 7028531
    [No Abstract] [Full Text] [Related]

  • 9. The treatment of hypertension in older patients: a double-blind, between-patient study, in previously treated patients comparing a diuretic, a beta-receptor antagonist, and their fixed combination.
    Forrest WA.
    J Int Med Res; 1981 Mar; 9(6):490-4. PubMed ID: 7033014
    [Abstract] [Full Text] [Related]

  • 10. Oxprenolol slow-release with cyclopenthiazide KCl in the treatment of essential hypertension. A multicentre general practice study.
    Levenstein JH.
    S Afr Med J; 1981 Jun 13; 59(25):893-9. PubMed ID: 7015537
    [Abstract] [Full Text] [Related]

  • 11. Trasidrex (a fixed combination of slow Trasicor 16o mg and Navidrex 0.25mg) in the treatment of hypertension: a multicentre clinical trial in general practice.
    Ebbut AF, Elsdon-Dew RW, Murphy JE.
    J Int Med Res; 1978 Jun 13; 6(6):494-8. PubMed ID: 720740
    [Abstract] [Full Text] [Related]

  • 12. An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study.
    Allman S, Norris RJ.
    J Int Med Res; 1990 Jun 13; 18 Suppl 2():17B-23B. PubMed ID: 2193840
    [Abstract] [Full Text] [Related]

  • 13. Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study.
    Crisp AJ, Kennedy PG, Hoffbrand BI, Ebbutt AF, Carruthers M.
    Curr Med Res Opin; 1980 Jun 13; 7(2):101-3. PubMed ID: 7002477
    [Abstract] [Full Text] [Related]

  • 14. A multicentre study examining the substitution of Trasidrex for the free combination of Slow-Trasicor and Navidrex-K.
    Ebbutt AF, Elsdon-Dew RW.
    J Int Med Res; 1979 Jun 13; 7(6):524-7. PubMed ID: 520655
    [Abstract] [Full Text] [Related]

  • 15. A study comparing indapamide with cyclopenthiazide in geriatric patients.
    Khan AU.
    Postgrad Med J; 1981 Jun 13; 57 Suppl 2():42-3. PubMed ID: 7033945
    [Abstract] [Full Text] [Related]

  • 16. Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.
    Levenstein JH.
    S Afr Med J; 1978 Nov 18; 54(21):860-4. PubMed ID: 371021
    [Abstract] [Full Text] [Related]

  • 17. Oxprenolol and a thiazide diuretic together in the treatment of essential hypertension--a large general practice study.
    Forrest WA.
    Br J Clin Pract; 1973 Sep 18; 27(9):331-5. PubMed ID: 4595072
    [No Abstract] [Full Text] [Related]

  • 18. Clinical and hemodynamic effects of high doses of slow release furosemide in arterial hypertension. A double-blind cross-over study with cyclopenthiazide.
    Krogsgaard AR, Trap-Jensen J, Hartling O, Svendsen TL.
    Acta Med Scand Suppl; 1976 Sep 18; 602():110-3. PubMed ID: 800315
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Studies on tienilic acid in hypertensive hyperuricaemic patients in Dunedin, New Zealand.
    Waal-Manning HJ, Bolli P, Wood AJ, Simpson FO.
    Postgrad Med J; 1979 Sep 18; 55 Suppl 3():85-91. PubMed ID: 388401
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.